Your search for smoking cessation returned 293 results

N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.

Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group.

High quality communication in tobacco treatment programs with lung cancer screenings was significantly associated with self-efficacy for smoking cessation.

The outpatient procedure provides noninvasive magnetic stimulation to areas of the brain known to be associated with addiction.

Guideline offers simple practice changes that may increase effectiveness of tobacco-dependence pharmacotherapy.

The Nonprescription Drugs Advisory Committee (NDAC) of the Food and Drug Administration (FDA) has recommended the approval of the New Drug Application (NDA) from GlaxoSmithKline for an over-the-counter (OTC) nicotine mouth spray to aid in smoking cessation (9 to 6 vote). The nicotine mouth spray (NMS) delivers 1mg nicotine per spray; each dispenser would deliver…

According to the results of a recent review, the efficacy of nicotine replacement therapy (NRT) in achieving long-term smoking cessation varies based on NRT delivery method, dosage, and timing of initiation.

Results from a placebo-controlled study evaluating Chantix (varenicline; Pfizer) in pediatric patients 12-16 years of age showed that the smoking cessation treatment was not associated with a significant increase in abstinence rates in this patient population.

One-year abstinence higher with e-cigarettes than other nicotine replacement products

E-cigarette use was 9.8% among current smokers, 1.1% among former smokers, and 0.6% among nonsmokers.